Phase II study of weekly amrubicin for refractory or relapsed non-small cell lung cancer

Chiyoe Kitagawa, Masahiro Iwasaku, Yoshihito Kogure, Masahiko Ando, Hiroshige Yoshioka, Akihiro Nishiyama, Naoki Watanabe, Kei Kunimasa, Kazuya Tsubouchi, Saori Oka, Hideo Saka

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of weekly amrubicin for refractory or relapsed non-small cell lung cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science